Publications

Analysis of evergreening and policy options Dutch National Healthcare Institute

Publication 11 March 2024

A comparison of the regulation of the statutory healthcare package in Western Europe

Publication 12 December 2023

An increasingly large piece of the pie - Forecast of expenditures on specialty drugs 2022-2026

Publication 5 July 2022

The financial ecosystem of pharmaceutical R&D

Publication 22 June 2022

A strong link - evaluation of the Good Use of Medicines programme

Publication 21 June 2022

The value of paediatric oncology

Publication 6 January 2022

Clarification of competition rules is helpful, but not a panacea for lower prices of prescription drugs

Publication 2 January 2020

The social impact of age-related hearing impairment

Publication 19 September 2019

Aiming for the ‘high-hanging fruit’ – evaluation of the Dutch expensive medicines policy 2016-2018

Publication 4 July 2019

Tapped potential - evaluation of the Efficiency Studies programme 2006–2017

Publication 26 September 2018